Exploring the Remarkable Benefits of Sip2Sleep: Insights from a Clinical Study
The results are in!
Sip2Sleep, our natural sleep aid combining Montmorency tart cherry extract and Venetron®, has been rigorously tested for its effectiveness in enhancing sleep quality and daytime alertness. We partnered with a third-party clinical study organization to obtain an in-depth analysis of how Sip2Sleep can help with sleep quality and daytime alertness! Let's explore the study's methodology, key findings, and the implications of the Insomnia Severity Index (ISI) and Generalized Anxiety Disorder-7 Assessment (GAD-7) scores.
Study Overview
Conducted over a span of four weeks, this observational study employed daily surveys, wearable device data, ISI, and GAD-7 scores to evaluate the impact of Sip2Sleep.
Key Findings
-
Improved Sleep Quality:
- A remarkable 84% of participants reported an increase in sleep quality while using Sip2Sleep.
- There was a significant rise in median sleep quality scores, especially in the latter part of the study.
-
Enhanced Daytime Alertness:
- Impressively, 88% of participants experienced an improvement in daytime alertness.
- This improvement was most notable when comparing data from Week 3 to Week 4.
-
Insomnia Severity Index (ISI):
- The ISI, a tool to assess insomnia severity, showed a notable decrease in scores, indicating reduced insomnia severity with Sip2Sleep.
-
Generalized Anxiety Disorder-7 Assessment (GAD-7):
- The GAD-7 scores, measuring anxiety severity, also showed a significant decrease, reflecting reduced anxiety symptoms among participants.
Understanding ISI and GAD-7
- The ISI's score reduction highlights Sip2Sleep's potential in alleviating insomnia symptoms.
- The GAD-7's decreased scores indicate Sip2Sleep's role in reducing anxiety, which is often a contributor to sleep problems.
Conclusion
The study's findings underscore Sip2Sleep's effectiveness in not only enhancing sleep quality, as evidenced by 84% of participants reporting improvements, but also in boosting daytime alertness, with 88% of participants experiencing benefits. Additionally, the significant changes in ISI and GAD-7 scores reinforce Sip2Sleep as a promising natural solution for managing sleep and anxiety-related issues.